Ceftazidime-avibactam for the treatment of infections caused by carbapenem-resistant Gram-negative pathogens in Chinese patients: A phase IV, multi-center, open‑label study. (linkinghub.elsevier.com)

Authors: Yuan J … Zhang Y Journal: International Journal of Antimicrobial Agents Published: 2026-10-03 DOI: https://doi.org/10.1016/j.ijantimicag.2026.108030